Answers are grounded in this paper and cite their sources.
A novel catalytic method produces C3-imidazolyl and pyridylquinoxalinones, indicating enhanced synthetic pathways.
A simple pseudofour-component reaction catalyzed by CuBr₂ has been developed to deliver C3-imidazoylquinoxalinones with decent yields from quinoxalin-2(1H)-ones, acetophenones, and ammonium persulfate in DMSO. This process follows a sequence of cross-dehydrogenative coupling/Kornblum oxidation/aza-cyclization, creating selectively four new C-C, two C-N, and C═N bonds. Interestingly, the Kornblum oxidation step can be skipped by simply replacing CuBr₂ with Cu(OAc)₂. This alteration leads to high-value C3-pyridylquinoxalinones. Notably, DMSO serves both as a C-H source for pyridine ring synthesis and an effective solvent for this conversion. In addition, the acquired 3-imidazolyl- and pyridylquinoxalinones were transmuted into value-added 3-(imidazo[1,2-a]pyrazin-3-yl)quinoxalinone and 2-sulfonylquinoxalines, showcasing the synthetic utility of our method.
No takes yet. Share an insight, caveat, or question.
Goud et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: